A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.
Zori Comba A, Blajman C, Richardet E, Bella S, Vilanova M, Cóppola F, Van Kooten M, Rodger J, Giglio R, Balbiani L, Perazzo F, Montiel M, Chacón M, Pujol F, Mickiewicz E, Cazap E, Recondo G, Lastiri F, Simon J, Wasserman E, Schmilovich A.
Zori Comba A, et al. Among authors: schmilovich a.
Eur J Cancer. 2001 May;37(8):1006-13. doi: 10.1016/s0959-8049(01)00080-6.
Eur J Cancer. 2001.
PMID: 11334726
Clinical Trial.